These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

396 related articles for article (PubMed ID: 6981365)

  • 1. Clinical significance of screening for antibody to ribonucleoprotein.
    Small P; Barrett D; Champlin E
    Ann Allergy; 1982 Sep; 49(3):152-5. PubMed ID: 6981365
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of antibodies to ribonucleoprotein and Sm antigens with mixed connective-tissue disease, systematic lupus erythematosus and other rheumatic diseases.
    Sharp GC; Irvin WS; May CM; Holman HR; McDuffie FC; Hess EV; Schmid FR
    N Engl J Med; 1976 Nov; 295(21):1149-54. PubMed ID: 1086429
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibodies to components of extractable nuclear antigen. Clinical characteristics of patients.
    Farber SJ; Bole GG
    Arch Intern Med; 1976 Apr; 136(4):425-31. PubMed ID: 1083722
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serial estimation of anti-RNP antibody titers in systemic lupus erythematosus, mixed connective tissue disease and rheumatoid arthritis.
    Nishikai M; Okano Y; Mukohda Y; Sato A; Ito M
    J Clin Lab Immunol; 1984 Jan; 13(1):15-9. PubMed ID: 6609234
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Significance of anti-ENA, Sm and RNP antibodies in patients with antinuclear antibodies.
    Levo Y; Lotan C
    Isr J Med Sci; 1982 Feb; 18(2):287-9. PubMed ID: 6978327
    [No Abstract]   [Full Text] [Related]  

  • 6. Patterns of clinical disease associated with antibodies to nuclear ribonucleoprotein.
    Maddison PJ; Mogavero H; Reichlin M
    J Rheumatol; 1978; 5(4):407-11. PubMed ID: 310884
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Mixed connective tissue disease, a clinical syndrome with anti-ribonucleoprotein antibodies].
    Elling H
    Ugeskr Laeger; 1978 Dec; 140(50):3140-2. PubMed ID: 310186
    [No Abstract]   [Full Text] [Related]  

  • 8. Antiribonucleoprotein antibodies in connective tissue diseases: estimation by counterimmunoelectrophoresis.
    Bresnihan B; Bunn C; Snaith ML; Hughes GR
    Br Med J; 1977 Mar; 1(6061):610-1. PubMed ID: 843832
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Joint lesions and antibodies to ribonucleoproteins in mixed connective tissue disease].
    Del'barr F; Del'r'e F
    Ter Arkh; 1980; 52(6):62-4. PubMed ID: 6967634
    [No Abstract]   [Full Text] [Related]  

  • 10. Free serum ribonucleoprotein in mixed connective tissue disease and other connective tissue diseases.
    Fishbein E; Ramos-Niembro F; Alarcon-Segovia D
    J Rheumatol; 1978; 5(4):384-90. PubMed ID: 310882
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mixed connective tissue disease.
    Prystowsky SD
    West J Med; 1980 Apr; 132(4):288-93. PubMed ID: 7385833
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical significance of antibodies to ribonucleoprotein.
    Cohen ML; Dawkins B; Dawkins RL; Owen ET
    Ann Rheum Dis; 1979 Feb; 38(1):74-8. PubMed ID: 312058
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical characteristics and course in patients with high titer anti-RNP antibodies.
    Lemmer JP; Curry NH; Mallory JH; Waller MV
    J Rheumatol; 1982; 9(4):536-42. PubMed ID: 6982334
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mixed connective tissue disease in childhood. A clinical and serologic survey.
    Singsen BH; Bernstein BH; Kornreich HK; King KK; Hanson V; Tan EM
    J Pediatr; 1977 Jun; 90(6):893-900. PubMed ID: 300795
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibodies against distinct nuclear matrix proteins are characteristic for mixed connective tissue disease.
    Habets WJ; de Rooij DJ; Salden MH; Verhagen AP; van Eekelen CA; van de Putte LB; van Venrooij WJ
    Clin Exp Immunol; 1983 Oct; 54(1):265-76. PubMed ID: 6352106
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Collagen-vascular diseases.
    Rothschild B
    Prim Care; 1984 Jun; 11(2):307-23. PubMed ID: 6566363
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical characteristics of patients with nuclear antiribonucleoprotein antibodies. Evidence of circulating immunocomplexes in mixed connective tissue disease].
    Rodríguez-Valverde V; Orte Martínez J; Sampedro Alvarez J; Peña Sagredo JL; Sánchez Andrada S
    Med Clin (Barc); 1982 Jun; 79(1):9-15. PubMed ID: 7121111
    [No Abstract]   [Full Text] [Related]  

  • 18. Problems in differentiating SLE and mixed connective-tissue disease.
    Reichlin M
    N Engl J Med; 1976 Nov; 295(21):1194-5. PubMed ID: 1086430
    [No Abstract]   [Full Text] [Related]  

  • 19. Frequency and clinical significance of antibodies to ribonucleoprotein in SLE and other connective tissue disease subgroups.
    Grennan DM; Bunn C; Hughes GR; Buchanan WW; Dick WC
    Ann Rheum Dis; 1977 Oct; 36(5):442-7. PubMed ID: 921344
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibodies against extractable nuclear antigens (ENA) in systemic scleroderma.
    Jabłońska S; Błaszczyk M; Górkiewicz A; Jarzabek-Chorzelska M; Rzesa G; Chorzelski T
    Arch Immunol Ther Exp (Warsz); 1978; 26(1-6):765-8. PubMed ID: 312085
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.